fluindione has been researched along with Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, P; Li, J; Liu, C; Na, F; Pu, Y; Wei, W; Yang, L; Yi, C; Yin, T; Zhang, L; Zhao, Y | 1 |
1 review(s) available for fluindione and Neoplasms
| Article | Year |
|---|---|
Incidence and risk factors of acute kidney injury in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
Topics: Acute Kidney Injury; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Humans; Immune Checkpoint Inhibitors; Incidence; Ipilimumab; Neoplasms | 2023 |